CFTR and cystic fibrosis: In parallel to the evaluation of CFTR function by HS-YFP assay, we performed shotgun proteomics on PBMCs isolated from four CF patients positively responding to VX770 treatment, in order to obtain a quantitative proteomic signature directly correlated to the effect of the therapy.